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THO/TREX, a conserved eukaryotic protein complex, is a key player at the interface between transcription
and mRNP metabolism. The lack of a functional THO complex impairs transcription, leads to transcription-
dependent hyperrecombination, causes mRNA export defects and fast mRNA decay, and retards replication
fork progression in a transcription-dependent manner. To get more insight into the interconnection between
mRNP biogenesis and genomic instability, we searched for HPR1 mutations that differentially affect gene
expression and recombination. We isolated mutants that were barely affected in gene expression but exhibited
a hyperrecombination phenotype. In addition, we isolated a mutant, hpr1-101, with a strong defect in tran-
scription, as observed for lacZ, and a general defect in mRNA export that did not display a relevant hyperre-
combination phenotype. In THO single-null mutants, but not in the hpr1 point mutants studied, THO and its
subunits were unstable. Interestingly, in contrast to hyperrecombinant null mutants, hpr1-101 did not cause
retardation of replication fork progression. Transcription and mRNP biogenesis can therefore be impaired by
THO/TREX dysfunction without increasing recombination, suggesting that it is possible to separate the
mechanism(s) responsible for mRNA biogenesis defects from the further step of triggering transcription-
dependent recombination.
Gene expression requires the correct coupling of transcrip-
tion to mRNA processing and export (7, 17, 30, 31). The final
outcome of transcription is a ribonucleoprotein particle
(mRNP) consisting of an mRNA molecule bound to proteins,
which later function in export, mRNA surveillance, and trans-
lation. Transcription and assembly of the mRNP are tightly
coordinated with the export of mRNA (42). A number of
proteins have been identified that are important for the correct
assembly of export-competent mRNP particles, including the
THO complex, composed of Tho2, Hpr1, Mft1, and Thp2, as
identified in Saccharomyces cerevisiae (9). THO has also been
purified from humans and Drosophila, in which Hpr1 and Tho2
homologues are present (32, 40). In yeast and humans, it has
been shown that THO is part of the TREX complex, which
includes the Sub2/UAP56 and Yra1/Aly mRNA export factors
(40). Functional connections between THO and the Sub2 and
Yra1 export factors have been shown by synthetic lethal phe-
notypes of double mutants and by multicopy suppression (11,
19, 40).
Null mutants of the THO complex are impaired in transcrip-
tion elongation (8, 23, 36). Additionally, these mutants exhibit
a plethora of phenotypes, including transcription-dependent
hyperrecombination (2), nuclear mRNA retention (40), and
fast mRNA degradation (22, 46), as well as synthetic lethality
in combination with mutations affecting transcription elonga-
tion such as spt4 (35) and with RNA export mutations such as
mex67-5 and yra1-1 (19, 40). Altogether, these data suggest
that THO plays a crucial role in mRNP metabolism at the
interface between transcription and mRNP export. Mutants
with changes affecting the Sub2-Yra1 component of TREX,
the Mex67-Mtr2 mRNA export factor, the Nab2 hnRNP, or
the Thp1-Sac3-Sus1 RNA export complex exhibit transcription
and genetic instability phenotypes similar to those of THO
mutants (12, 14, 19).
The THO complex is exclusively recruited to transcribed
chromatin (20, 40, 46). Recruitment of the Sub2 and Yra1
components of the THO/TREX complex to transcribed DNA
is partially dependent on THO (46). In contrast to THO, bind-
ing of Sub2 to transcribed chromatin is RNA dependent (1).
The relevance of THO in the early steps of mRNP biogenesis
is supported by the observation that transcription impairment
in hpr1 mutants is suppressed if the nascent mRNA is self-
cleaved by an artificially engineered hammerhead ribozyme. In
these mutants, the nascent mRNA can form RNA-DNA hy-
brids (R loops) linked to both impairment of transcription and
transcription-associated recombination (18). The observation
that depletion of the vertebrate ASF/SF2 splicing factor in
chicken DT40 cells and human HeLa cells also leads to
genomic instability linked to R loop formation (21) indicates
that a number of mRNA processing enzymes may have a role
in preventing RNA-dependent structures that trigger genome
instability. Our current view is that the THO complex partici-
pates in cotranscriptional assembly of export-competent
mRNP during transcription elongation and contributes to the
prevention of the RNA from forming structures that hamper
transcription and could compromise genome stability (3).
Despite the link between impaired transcription and hyper-
recombination in THO mutants, it is not clear whether im-
paired gene expression by itself is sufficient to induce hyper-
recombination or whether hyperrecombination is possible in
the absence of impaired gene expression. Thus, we searched
for THO mutants compromised in gene expression that did not
affect genetic integrity and vice versa. Hyperrecombination
* Corresponding author. Mailing address: CABIMER, Av. Americo
Vespucio s/n, 41092 Seville, Spain. Phone: 34 954 468372. Fax: 34 954
461664. E-mail: aguilo@us.es.
 Published ahead of print on 14 August 2006.
7451



























mutations that did not have a significant effect on transcription
were not found. Instead, we isolated a new allele, hpr1-101
(L586P), which causes a strong decrease in transcript accumu-
lation but does not show a relevant hyperrecombination phe-
notype. The in vivo stability of THO and its subunits was
strongly reduced in THO-null mutants such as hpr1 but not in
hpr1 point mutants. The absence of associated hyperrecombi-
nation seems to be due to the fact that, in contrast to hpr1,
transcription impairment in hpr1-101 does not hamper repli-
cation fork progression. Our results indicate that THO dys-
function can cause transcription defects that are not linked to
impairment of replication fork progression, opening the pos-
sibility that THO links optimal mRNP biogenesis with tran-
scription elongation, apart from its effect on genomic integrity.
MATERIALS AND METHODS
Strains and plasmids. The strains used in this study are listed in Table 1. All
of the strains are isogenic to W303-1A, except LAU3-10A and LAU3-10D, which
are congenic segregants from a SChY58A  AYW3-1B cross. Strains
WH101-1A and WH103-1A, isogenic to W303-1A but harboring the hpr1-101
and hpr1-103 alleles in the HPR1 chromosomal locus, were obtained by gene
replacement in SChY58a (hpr1::KAN). Plasmids pRS313, pRS316 (38), YCp70,
YCpA13 (4), pRS314GLlacZ (15), YEp351-SUB2, pCM184-LAUR (19),
pRS316-GAL1lacZ, pSCh202, pSCh204, pSCh206 (8), pPHO5-Rib-lacZ
(Rib), pPHO5-ribm-lacZ (ribm), pGL-Rib, pGL-ribm (18), and pRWY005
(43) have been described previously. Plasmid pRS313-GZ was constructed by
cloning the GAL1pr::lacZ fusion from pRS316-GAL1lacZ into pRS313 in vivo as
previously described (29). pRS316-HPR1 was obtained by cloning the 6.55-kb
HindIII HPR1 fragment from YCpA13 into the HindIII site of pRS316. Plasmids
YCphpr1-101 to YCphpr1-104 were obtained by in vivo cloning of linear mu-
tagenized HPR1 PCR fragments into YCp70 in yeast strain LAU3-10A as de-
scribed below.
New hpr1 alleles obtained by random mutagenesis. In vitro mutagenesis of
HPR1 was performed according to reference 27, with some modifications. PCR
amplification of HPR1 was done under suboptimal conditions with 3.25 mM
MgCl2, 0.25 mM MnCl2, 0.2 mM dTTP, 0.2 mM dGTP, 0.2 mM dCTP, 0.04 mM
dATP, and 1.75 U of Expand High Fidelity Taq polymerase (Roche). YCpA13 (1
g) was used as the template, and the oligonucleotides 5 GCCACGTTTGTT
TACTCG 3 and 5 CTATCATCCAACGCTTCC 3 were used as primers. The
LAU3-10A strain (hpr1), previously transformed with pRS313-GZ, was co-
transformed with the purified, PCR-mutagenized HPR1 mixture and the linear
BamHI-XbaI fragment of YCpA13, which corresponds to YCp70 carrying 200 bp
of HPR1 flanking sequences on each side. In vivo recombination between the
PCR-induced hpr1 alleles and the linear vector led to formation of the YCphpr1
plasmids in the cells. Transformants thus obtained were plated on synthetic
complete (SC) medium without histidine and leucine containing limited amounts
of adenine (1.5 mg/liter) for visualization of red sectors resulting from recom-
bination of the chromosomal leu2-k::ADE2-URA3::leu2-k repeat system. Colo-
nies were then replicated onto SC without histidine and leucine containing 2%
galactose to allow expression of the GAL1pr::lacZ fusion. On the following day,
a solution containing 0.25 M phosphate buffer (pH 7.5), 0.1% sodium dodecyl
sulfate (SDS), 400 g/ml 5-bromo-4-chloro-3-indolyl--D-galactopyranoside (X-
Gal), and 0.5% agarose was added and -galactosidase activity was scored by blue
color formation after 2 h at 30°C. Colonies transformed with either YCpA13 or
YCp70 were used as positive (wild type) or negative (hpr1) controls, respectively.
Purification of the THO complex and analysis of its subunits. The THO
complex was purified by using the C-terminally tandem affinity purification
(TAP) epitope-tagged Tho2 protein and following standard procedures (33) and
using specifications previously reported (19). Mft1 was detected by Western
analysis of purified THO complexes previously separated by 10% SDS-poly-
acrylamide gel electrophoresis (PAGE) and transferred to nylon membranes.
After treatment with phosphate-buffered saline containing 0.1% Tween 20 and
5% milk, proteins were detected with anti-Mft1 antibody and peroxidase-conju-
gated goat anti-rabbit immunoglobulin G (IgG). Blots were washed with phos-
phate-buffered saline–0.1% Tween 20 and developed by enhanced chemilumi-
nescence reactions (Amersham). The Tho2-TAP epitope fusion was detected in
whole cell extracts with peroxidase antiperoxidase (PAP; Sigma) antibody by
following the manufacturer’s instructions as described previously (19).
2D gel analysis of replication intermediates. Cells were grown overnight to an
optical density at 600 nm of 0.2 to 0.3 in SC medium containing 1% glycerol-
lactate and 1% raffinose as a carbon source. After bringing the culture to 2%
galactose, cells were grown for another 3.5 to 4 h prior to DNA isolation. DNA
of 100 ml of cells was isolated with cetyltrimethylammonium bromide (44),
dissolved in a final volume of 100 l of Tris-EDTA, and stored at 4°C. Prior to
analysis, 50 l of DNA was double digested with SmaI-SacI. After digestion,
DNA was precipitated and subjected to two-dimensional (2D) gel electrophore-
sis as described previously (6), with the following modifications. DNA was sep-
arated for 20 h in the first dimension on a 0.5% agarose gel at 1 V/cm and for
14 h in the second dimension on a 1.2% agarose gel at 4 V/cm and 4°C in the
presence of 0.3 g/ml ethidium bromide. After alkaline transfer of the DNA onto
a Hybond-N membrane, the membrane was hybridized against a 32P-labeled
1.2-kb fragment obtained by PCR covering ARS1 and part of the 3-lacZ gene.
Membranes were exposed on a Fuji 3600 Phosphorimaging system and analyzed
with the imaging software supplied.
ChIP. Recruitment of Sub2, Tho2, and RNAPII to chromatin was determined
by chromatin immunoprecipitation (ChIP) analyses on the endogenous PMA1
gene in yeast strains containing a 5-end TAP epitope-tagged version of either
the SUB2 or the THO2 gene inserted at its chromosomal locus, as previously
described (16). Briefly, immunoprecipitations were performed with Ig-Sepharose
for TAP epitope-tagged proteins or with anti-Rpb1-CTD monoclonal antibody
TABLE 1. Yeast strains used in this study
Strain Genotype Source or reference
W303-1A MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 R. Rothstein
AYW3-1B MAT ade2 can1-100 his3 trp1 ura3 leu2-k::ADE2-URA3::leu2-k 13
U768-4C W303-1A hpr1::HIS3 R. Rothstein
SChY58a W303-1A hpr1::KAN S. Chávez
WH101-1A W303-1A hpr1-101 This study
WH103-1A W303-1A hpr1-103 This study
BSU-S2T-6D MATa ade2-1 leu2 hpr1::HIS3 SUB2-TAP 19a
LAU3-10A MATa ade2-1 his3-11,15 trp1-1 ura3-1 This study
leu2-k::ADE2-URA3::leu2-k hpr1::KAN
LAU3-10D MAT ade2-1 his3-11,15 trp1-1 ura3-1 leu2-k::ADE2-URA3::leu2-k This study
WMC1-1A W303-1A mex67-5 19
WMH1 hpr1::KAN mex67-5 isogenic to W303-1A and transformed with pRS316-HPR1 This study
WWT2T W303-1A THO2-TAP 19a
WTT3-4A W303-1A THO2-TAP hpr1-101 This study
WTT3-4C W303-1A THO2-TAP hpr1::KAN This study
STT2 W303-1A THO2-TAP sub2::HIS3 19
MTT1 W303-1A THO2-TAP mft1::KAN S. Jimeno
WTT4-5C W303-1A THO2-TAP hpr1-103 This study
WHYL.2A W301-1A hpr1::HIS3 GAL1pr::YRL454 19a
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8WG16 (Berkeley Antibody Company) and protein A-Sepharose for RNA poly-
merase II (RNAPII). The GFX purification system (Amersham) was used for the
last DNA purification step. We used 20- to 27-bp oligonucleotides for PCR
amplification of PMA1 sequences. For Tho2 recruitment, we amplified two
fragments, localized at positions 292 to 321 and 2273 to 2242, whereas for Sub2
and RNAPII recruitment, we only amplified the 2273-to-2242 fragment. In both
cases, we used the PCR of the intergenic region at positions 9716 to 9863 of
chromosome V as a negative control. The PCR products obtained were electro-
phoresed in a 15% acrylamide gel, stained with ethidium bromide, and quantified
in a Fuji FLA-3000. The relative abundance of each DNA fragment was calcu-
lated as the ratio of each DNA fragment to the intergenic-region quantification
results of the precipitated fractions normalized with respect to the corresponding
ratios of the input fractions.
For analysis of RNAPII processivity, a strain harboring either YLR454 or
lacZ under the control of the GAL1 promoter was used (23). RNAPII abun-
dances at different positions of the genes were assayed as indicated, by using
ChIP with anti-Rpb1-CTD monoclonal antibody 8WG16 and protein A-
Sepharose as previously described (23). We used 20- to 30-bp oligonucleo-
tides for PCR amplification of two fragments of YLR454, positions 3 to 43
and 7621 to 7674; of two fragments of lacZ, positions 715 to 1025 and 2247
to 2467; and of the 9716-to-9863 intergenic region of chromosome V that was
used as a control. Real-time quantitative PCR was performed with SYBR
green dye in the 7500 Real Time PCR system of Applied Biosystems by
following the manufacturer’s instructions.
Miscellanea. Recombination frequencies were calculated as previously de-
scribed (18). For each genotype, the recombination frequencies are given as the
average and standard deviation of the median recombination value obtained
from two or three different transformants with 6 to 12 independent colonies per
transformant. -Galactosidase and phosphatase assays and Northern analyses
were performed according to previously published procedures (18). mRNA ex-
port assays were performed by in situ poly(A) RNA localization with a synthetic
digoxigenin-labeled oligo(dT)20 as previously described (5, 14).
RESULTS
Isolation of hpr1 mutations with differential effects on gene
expression and genetic instability. Mutagenic PCR-generated
hpr1 alleles were cloned into the YCp70 plasmid by in vivo
homologous recombination (see Materials and Methods). hpr1
mutations that differentially affected gene expression and re-
combination were screened by a color assay based on the
chromosomal leu2-k::ADE2-URA3::leu2-k direct-repeat con-
struct (4). With this construct, wild-type cells form white col-
onies (Ade) whereas hpr1 cells form red-sectoring colonies
(Ade Ade). Defects in gene expression were determined
with a GAL1pr::lacZ fusion construct which results in a dark
blue color in expression-competent wild-type colonies and a
light blue color in expression-deficient hpr1 mutant colonies.
Screening of 5,346 transformant colonies permitted the iden-
tification of four hpr1 mutants (hpr1-101 to hpr1-104) which,
upon subsequent analyses, were verified as being preferentially
hyperrecombinant or defective in lacZ expression. The hpr1
alleles were sequenced, and the mutations responsible for the
amino acid changes of each allele were determined (Fig. 1A).
hpr1-101 harbors two point mutations, but only one (L586P)
leads to amino acid substitution. Interestingly, although the
primary sequence of the Hpr1 protein is not particularly con-
served, this mutation lies in a highly conserved region (Fig.
1B). hpr1-102 has a 1 frameshift that leads to a premature
stop codon and a carboxy-terminally truncated Hpr1 protein.
hpr1-103 and hpr1-104 harbor multiple point mutations leading
to 12 and 6 amino acid substitutions, respectively.
Next, recombination frequencies and -galactosidase activ-
ities were determined in a LAU3-10A hpr1 strain carrying the
leu2-k::ADE2-URA3::leu2-k and GAL1pr::lacZ systems, re-
spectively, and transformed with the YCp70::hpr1 series of
plasmids (hpr1-101 to hpr1-104), YCpA13 (HPR1), or the
empty vector YCp70 (hpr1) (Fig. 1C). hpr1 cells display a
strong reduction in -galactosidase activity (a 25-fold de-
crease) that correlates with a strong increase in recombination
(773-fold above the wild-type level). Like hpr1 cells, hpr1-101
and hpr1-102 cells exhibit a significant reduction in -galacto-
sidase activity (4.3- and 6.7-fold decreases, respectively) which,
in contrast to hpr1, was accompanied by a weak increase in
recombination (5- and 50-fold, respectively). Instead, -galac-
tosidase activity in hpr1-103 and hpr1-104 cells was poorly
affected (1- to 2-fold decreases), while recombination values
(239- and 567-fold above the wild-type level) were close to the
values obtained in hpr1. We therefore decided to further
analyze hpr1-101 and hpr1-103 in order to understand the basis
for the different phenotypes they produce.
hpr1-101 causes a gene expression defect not associated with
hyperrecombination, whereas hpr1-103 affects both gene ex-
pression and recombination. The strength of the gene expres-
sion defect and hyperrecombination phenotypes of hpr1 has
been shown to be dependent on the DNA sequence (10). Thus,
transcription through the lacZ bacterial gene is severely com-
promised in hpr1 and leads to strong hyperrecombination,
but the transcription defect and hyperrecombination pheno-
types are weak or barely detectable in other DNA sequences,
such as that of PHO5. To understand the connection between
the gene expression and recombination phenotypes observed
in the hpr1 point mutants, we further analyzed the most rep-
resentative alleles, i.e., hpr1-101 (strong gene expression defect
and weak hyperrecombination) and hpr1-103 (weak gene ex-
pression defect and strong hyperrecombination). Thus, we con-
structed isogenic strains harboring single chromosomal copies
of hpr1-101 (WH101-1A) and hpr1-103 (WH103-1A) at the
HPR1 locus by gene replacement.
Recombination analysis in the L-lacZ system, containing
lacZ flanked by leu2 direct repeats, revealed that, compared to
hpr1 (recombination 87-fold above the wild-type level), hy-
perrecombination was weak in hpr1-101 (8-fold) and moderate
in hpr1-103 (20-fold) (Fig. 2A). Next, we analyzed recombina-
tion in the L-PHO5 and GL-lacZ systems, the latter of which is
the same as L-lacZ except that transcription is driven by the
GAL1 promoter. With either actively transcribed L-PHO5 or
GL-lacZ under repressive conditions (2% glucose), we ob-
tained wild-type recombination levels in the L-PHO5 and GL-
lacZ systems in both hpr1-101 and hpr1-103, respectively.
These results indicate that hyperrecombination was transcrip-
tion and sequence dependent in both mutants. In order to
determine whether transcription impairment and hyperrecom-
bination in these mutants are associated, we analyzed tran-
script levels in the same system used to measure recombina-
tion. Northern analysis showed similar L-PHO5 transcript
levels for all of the strains (Fig. 2B). Importantly, in the hpr1-
103 mutant the transcript levels of lacZ mRNA expressed from
the L-lacZ system only reached 75 to 80% of the wild-type
levels, which clearly differs from the -galactosidase results
obtained in the GAL1pr::lacZ system (Fig. 1C and data not
shown). Thus, when transcription was analyzed in the same
system in which hyperrecombination was detected, the hpr1-
103 mutant showed the same phenotypes as hpr1, although to
a lesser extent. As the L-lacZ and GAL1pr::lacZ systems differ
in the length of the transcribed DNA sequence, it seems that
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the hpr1-103 effect on transcription was detectable in long
DNA sequences. This is consistent with previous observations
indicating that hyperrecombination is only observed in associ-
ation with a detectable transcription defect (2).
RNAPII processivity is impaired in hpr1-101 mutants. Since
hpr1-101 did not display a significant hyperrecombination phe-
notype compared with hpr1, we wondered whether this mu-
tation leads to a real impairment in RNAPII transcription, as
is the case for hpr1 strains. First we determined gene expres-
sion from GAL1pr::lacZ and GAL1pr::PHO5 in hpr1-101 mu-
tant cells compared to wild-type and hpr1 cells. As shown in
Fig. 3A, whereas -galactosidase activity was clearly dimin-
ished in hpr1-101, acid phosphatase was not affected. This
pattern is similar, although to a lesser extent, to the results
obtained for the null hpr1 strain.
Next, we determined whether the reduction of mRNA levels
in hpr1-101, as in hpr1, was different, depending on the gene
tested. We analyzed the mRNA levels in various open reading
frames (ORFs) driven by the strong GAL1 promoter. These
ORFs included lacZ from Escherichia coli (3 kb and 53% GC
content); PHO5 (1.5 kb and 40% GC), YAT1 (2 kb and 51%
GC), and YRL454 (8 kb and 41% GC) from S. cerevisiae; and
LAC4 (3 kb and 41% GC) from Kluyveromyces lactis. As shown
in Fig. 3B, hpr1-101 causes a reduction as great as that pro-
duced by hpr1 in the mRNA levels of lacZ and YRL454 but
has little effect on PHO5, consistent with the enzymatic anal-
ysis (Fig. 1). However, it has only a moderate effect on YAT1
and LAC4 mRNA levels. These results suggest that the
strength of the deficiency in mRNA accumulation in hpr1-101
cells is also ORF dependent.
In hpr1 strains, RNAPII processivity, defined as the ability
of RNAPII to travel the entire length of a gene, is impaired
(23). Although mRNA levels were affected in hpr1-101, it was
conceivable that RNAPII processivity was not impaired in this
strain, therefore separating RNAPII processivity from hyper-
recombination. To test this hypothesis, we determined the pro-
cessivity of RNAPII in hpr1-101 along the lacZ and YRL454
genes by ChIP. This was performed with an anti-Rpb1 anti-
FIG. 1. Genetic characterization of hpr1 point mutations that differentially affect transcription and recombination. (A) Schematic represen-
tation of the amino acid substitutions of the hpr1 alleles studied. Mutations that change the amino acid sequence are represented as black bars.
(B) Protein alignment of the region surrounding L586 in several Hpr1 orthologs. The Hpr1 protein sequences used belong to the followings
organisms: S. cerevisiae wild type and hpr1-101 mutant (Sc WT and Sc 101, respectively), Saccharomyces bayanus (SBay), Homo sapiens (Hsap),
Mus musculus (Mmus), Xenopus laevis (Xlae), Brachydanio rerio (Brer), Drosophila melanogaster (Dmel), Saccharomyces kluyveri (Sklu), Caeno-
rhabditis elegans (Cele), Arabidopsis thaliana (Atha), Dictyostelium discoideum (Ddis), Neurospora crassa (Ncra), and Schizosaccharomyces pombe
(Spom). (C) -Galactosidase activity and recombination frequencies of the LAU3-10A (hpr1) strain containing the leu2-k::ADE2-URA3::leu2-k
recombination system and transformed with pRS313-GZ (containing the GAL1pr:::lacZ fusion) and with either YCpA13 (HPR1), YCp-hpr1-101
to YCp-hpr1-104 (hpr1-101 to hpr1-104), or the empty vector YCp70. The percentage of -galactosidase activity with respect to the wild-type level
(taken as 100%) is shown. Each value represents the average of two or three independent experiments. The recombination frequencies (104) are
averages of two to four median frequencies obtained from the same number of fluctuation experiments.
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body and quantitative standard and real-time PCRs at the 5
end and 3 end of each coding sequence. As shown in Fig. 4,
RNAPII is significantly reduced toward the 3 end of lacZ in
hpr1, as well as hpr1-101 (Fig. 4A). In YRL454, RNAPII was
significantly reduced at the 3 end in the hpr1 strain and to a
lesser extent in the hpr1-101 strain (Fig. 4B). These results are
consistent with the mRNA accumulation results observed for
each gene and indicate that RNAPII processivity is diminished
in hpr1-101. Thus, we conclude that impaired RNAPII proces-
sivity by itself is not sufficient to lead to hyperrecombination.
Instead, in hpr1-103, RNAPII processivity along lacZ was not
affected (Fig. 4B), in agreement with the expression data (Fig.
1C), but it was affected for the long (8-kb) YLR454 ORF to the
same extent as in hpr1-101 (Fig. 4B). This is consistent with the
conclusion that hpr1-103 affects transcription to a minor de-
gree but sufficiently to cause transcription-dependent hyperre-
combination.
Nuclear accumulation of poly(A) RNA in hpr1-101 and
hpr1-103 mutants. The transcriptional defect of THO-null mu-
tants such as hpr1 has been shown to be associated with
nuclear accumulation of poly(A) RNA caused by defects in
mRNA export (19, 40). The functional relationship of THO
with mRNA export is provided by the synthetic lethality of
RNA export factor mutants in the absence of a functional
THO complex, as demonstrated by the hpr1 mex67-5 ts double
mutants. To explore whether the hpr1-101 and -103 point mu-
tants were affected in RNA export, we first determined the
capacity of the new mutations to rescue the synthetic lethality
of the hpr1 mex67-5 mutant. For this, we constructed hpr1
mex67-5 strains carrying a URA3-based plasmid containing
wild-type HPR1. These strains were transformed with a plas-
mid containing either mutant allele hpr1-101 or hpr1-103, and
the capacity of each allele to rescue hpr1 mex67-5 lethality
was determined by growth in SC medium plus 5-fluoroacetic
acid (FOA). As shown in Fig. 5A, the ability of each hpr1 allele
to rescue hpr1 mex67-5 lethality is linked to its transcriptional
defect. hpr1-103, which had little effect on gene expression,
almost completely rescued the synthetic lethality, whereas
FIG. 2. Recombination in hpr1-101 and hpr1-103 mutants. (A) The isogenic strains W303-1A (WT), WH101-1A (hpr1-101), WH103-1A (hpr1-103),
and SChY58a (hpr1), carrying the mutant alleles integrated in the chromosomal HPR1 locus, were transformed with plasmid pSCh204 (L-lacZ
recombination assay) or pSCh206 (L-PHO5 recombination assay). Gray boxes represent LEU2 repeats that flank either the PHO5 or the lacZ ORF, as
indicated. The white box represents the promoter, and the white solid arrow represents the CYC transcription termination site. Shown are recombination
frequencies under repressed conditions (glucose) in cells transformed with plasmid pRS314GLlacZ, containing the GL-lacZ recombination assay, in
which transcription is under the control of the GAL1 promoter. The recombination frequencies shown are averages of two to four different experiments.
(B) Northern analysis of the L-lacZ and L-PHO5 recombination system in isogenic strains W303-1A (WT [wild type]), WH101-1A (hpr1-101), and
SChY58a (hpr1) transformed with either pSCh204 or pSCh206, respectively. Filters were hybridized with either a lacZ or a PHO5 probe and with the
25S rRNA probe. All data were normalized with respect to the rRNA signal. The averages of two experiments are plotted. A.U., arbitrary units.
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hpr1-101, which confers strong transcription defects, did not,
suggesting a direct correlation between transcription and im-
paired mRNA export. Analysis of other hpr1 alleles isolated in
this study, such as hpr1-102 and hpr1-104, confirmed this cor-
relation between transcription defect and synthetic lethality
with mex67-5 (data not shown).
We next analyzed the nuclear export of poly(A) mRNA by
in situ hybridization with a 20-mer oligo(dT) fluorescent probe
in the wild-type, hpr1-101, hpr1-103, and hpr1 strains (Fig.
5B). Incubation of the cells at 37°C led to nuclear poly(A)
mRNA accumulation in hpr1 and hpr1-101 cells. However, in
hpr1-103 cells, mRNA accumulation was only observed after
6 h of incubation at 37°C. These results indicate that the gene
expression defect in hpr1 and hpr1-101 cells directly corre-
lates with their mRNA export defect.
Transcription impairment in hpr1-101 and hyperrecombi-
nation in hpr1-103 are dependent on the nascent mRNA mol-
ecule. The transcription impairment and hyperrecombination
phenotypes of hpr1 cells have been shown to be dependent on
structures mediated by the nascent mRNA (18). To assay the
FIG. 3. Transcription analysis of hpr1-101 versus the wild type and hpr1 as a function of GC content and the length of the transcribed DNA
sequence. (A) Isogenic strains W303-1A (WT [wild type]), WH101-1A (hpr1-101), and SChY58a (hpr1), carrying the mutant alleles integrated
into the chromosomal HPR1 locus, were transformed with pRS316-GAL1lacZ (GAL1pr::lacZ fusion) or pSCh202 (GAL1p::PHO5 fusion).
-Galactosidase or phosphatase activity was defined as the percentage (for lacZ or PHO5, respectively) of the wild-type activity, which was taken
as 100%. The mean and standard deviation of three independent experiments are plotted. (B) Northern analysis of mRNA levels in different
plasmid constructs containing lacZ (pRS416GAL1lacZ), PHO5 (pSCH202), LAC4 (pSCH255), and YAT1 (pSCH247) under the control of the
GAL1 promoter in strains W303-1A (wild type), WH101-1A (hpr1-101), and U768-4C (hpr1). For the analysis of transcription of the YLR454
gene, strain WHYL.2A (hpr1 GAL1p::YLR454) was transformed with the empty vector YCpA70 (hpr1) or with plasmid YCpA13 (HPR1) or
YCp:hpr1-101 (hpr1-101). Others details are the same as those in Fig. 2B.
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effect of the nascent mRNA on transcription, we used the
previously defined Rib and ribm constructs (Fig. 6A), in
which a PHO5-Rib-lacZ transcriptional fusion containing ei-
ther a wild-type (Rib) or a mutated (ribm) Hammerhead
ribozyme sequence was placed under the control of the GAL1
promoter (18). In both constructs, a 2.2-kb long mRNA is
transcribed, but in the Rib construct the active hammerhead
ribozyme cleaves the transcript, liberating a 1.8-kb mRNA.
Meanwhile, RNAPII travels farther, producing a 0.6-kb
mRNA. Northern analysis of the ribm construct revealed that
less transcript was accumulated in hpr1 and hpr1-101 cells
than in wild-type and hpr1-103 cells. However, ribozyme cleav-
age in the Rib construct led to an increase in the resulting
0.6-kb transcript so that similar mRNA levels were found in all
strains.
Apparently, ribozyme cleavage was capable of increasing the
amount of mRNA transcripts in hpr1 and hpr1-101 cells. In a
previous work, we showed that ribozyme cleavage was capable
of partially suppressing the hyperrecombination phenotype ob-
served in hpr1 cells. Thus, we asked whether ribozyme cleav-
age might also be sufficient to reduce the hyperrecombination
phenotype observed in hpr1-103 cells. Hyperrecombination
was assayed with the GL-Rib and GL-ribm repeat systems
containing PHO5, followed by active Rib or inactive ribm
sequences between 0.6-kb-long leu2 direct repeats, respectively
(Fig. 6B). In the GL-ribm system, recombination was strongly
increased in hpr1 (285-fold), moderately increased in hpr1-
103 (17-fold), and poorly affected in hpr1-101 (3-fold). In all
three strains, recombination levels were reduced two- to three-
fold by the ribozyme-mediated cleavage of the nascent mRNA.
Therefore, both the transcription defect of hpr1-101 and the
hyperrecombination of hpr1-103 are similarly dependent on
the nascent mRNA, as shown for hpr1 mutants.
Differential stability and recruitment of the THO complex in
hpr1-101 and hpr1-103 versus THO-null mutants. The THO
complex is a highly stable complex which can be purified with
salt concentrations as high as 1.2 M and remains stable in vivo
in mutants of the TREX complex such as sub2 (9, 19). How-
ever, the integrity of the THO complex has not been studied in
mutants of the THO subunits. To determine whether the dif-
ferent phenotypes of hpr1-101, hpr1-103, and the THO-null
mutants were related to the stability of THO, the complex was
purified from the different mutant strains. With a TAP
epitope-tagged Tho2 protein, the complex was purified from
whole cell extracts derived from wild-type, hpr1-101, hpr1-103,
hpr1, mft1, and sub2 strains by two-step affinity purifica-
tion (19, 33). Western blot analysis with a PAP antibody
showed that the amount of TAP-Tho2 was similar in whole cell
extracts of hpr1-101 and wild-type cells (Fig. 7A). Although
TAP-Tho2 seems slightly reduced in hpr1-103 and sub2 and
the amount of Tho2 varies between experiments (Fig. 7A), it
was similar in all cases to that in wild-type cells. In contrast, in
FIG. 4. RNA processivity is affected by hpr1-101 in a manner strongly dependent on the GC content and moderately dependent on the length
of the transcribed DNA sequence. (A) ChIP assays of RNAPII at the lacZ gene. Experiments were performed with strains W303 (WT [wild type]),
WH101-1A (hpr1-101), and U768-4C (hpr1) transformed with plasmid pRS416GAL1lacZ containing lacZ under the control of the GAL1
promoter. ChIPs with regions 1 and 2 and an intergenic region as a control were performed in two different transformants, and PCRs were repeated
four times for each transformant. The ratio of DNA in regions 1 and 2 was calculated from the DNA amounts in regions 1 and 2 relative to the
DNA amount obtained from the intergenic region. Values were normalized to the amount of DNA in region 1 in each strain, which was set to 100%
(for details, see Materials and Methods). (B) ChIP assays of RNAPII at the YLR454 gene under control of the GAL1 promoter. The experiments
were performed with strain WHYL.2A (hpr1 GAL1p::YLR454) containing either plasmid YCpA13 (HPR1) or YCphpr1-101 (hpr1-101) or the
empty vector YCpA70 (hpr1). ChIPs were performed with two different transformants each, and quantitative PCRs were repeated twice for each
transformant. Values were normalized to the amount of DNA in region 1 of each transformant, which was set to 100%.
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hpr1 and mft1, loading of similar amounts of cell extract
onto the gel did not permit detection of a signal corresponding
to the full TAP-Tho2 protein (Fig. 7A). Only when 10-fold
more whole cell extract was loaded was a weak signal corre-
sponding to the TAP-Tho2 protein detectable (Fig. 7A). As
THO2 transcript levels have been found to be similar in wild-
type and hpr1 cells (13), the decrease in Tho2 must result
from a posttranscriptional effect, suggesting that THO subunits
may only be stable in the form of a complex.
Analysis of the TAP-Tho2 purified THO complex by gradi-
ent SDS-PAGE revealed that in the wild type, hpr1-101, hpr1-
103, and sub2, the four THO subunits (Tho2, Hpr1, Mft1,
and Thp2) were present (Fig. 7B). However, in hpr1 and
mft1, only the TAP-Tho2 protein was enriched by the TAP
system. Thus, if one of the core proteins of THO is missing, the
integrity of the THO complex is greatly reduced. In order to
find out whether the remaining proteins form at least some
kind of complex, we used an anti-Mft1 antibody to detect
FIG. 5. mRNA export defects of hpr1 mutants. (A) Suppression of hpr1 mex67-5 synthetic lethality. Strain WMH1 (hpr1 mex67-5)
transformed with URA3-based plasmid pRS316-HPR1 was additionally transformed with LEU2-based plasmids YCpA13 (HPR1), YCp-hpr1-101
(hpr1-101), and YCp-hpr1-103 (hpr1-103) or the empty vector YCp70 (hpr1). Transformants were spotted in 10-fold serial dilutions on selective
medium with or without FOA. Plates were scanned after 3 days of incubation at 30°C. Note that only transformants harboring alleles suppressing
the synthetic lethality are able to grow on SC medium-FOA plates. (B) Analysis of nuclear poly(A) RNA localization in W303-1A (wild type),
WH101-1A (hpr1-101), WH103-1A (hpr1-103), and U768-4C (hpr1) log-phase cultures cultivated for 3 or 6 h at 37°C, as indicated. Samples were
immobilized in Teflon-coated slides and hybridized first with a digoxigenin-labeled 20-mer oligo(dT) and second with a fluorescein-conjugated
anti-digoxigenin antibody for in situ detection of mRNA. Nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI). U, uracil; L, leucine.
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remaining traces of Mft1 in the TAP-Tho2 purified samples.
Similar amounts of Mft1 were detected in wild-type, hpr1-101,
hpr1-103, and sub2 cells, whereas no signal was detected in
hpr1 and mft1 cells when similar amounts of TAP-purified
Tho2 were loaded (Fig. 7C). However, when 10-fold more
Tho2 protein was loaded onto the gel, Mft1 could be detected
in hpr1 TAP-Tho2 purified fractions (Fig. 7C). These results
indicate that the THO complex is unstable if one of its com-
ponents is absent, such as Hpr1 or Mft1, but is stable in both
the hpr1-101 and hpr1-103 mutants, as well as in mutants in
which a TREX component, such as Sub2, is absent.
Since, contrary to hpr1, THO is stable in hpr1-101 and
hpr1-103 cells, we wondered if THO was also recruited into
active chromatin in these mutants. With the same TAP-Tho2
strains as before, we found that hpr1-101 and hpr1-103 re-
cruited the TAP-Tho2 subunit of THO to a transcriptionally
active PMA1 gene (Fig. 8) at levels clearly above that of hpr1
mutants. Therefore, the two point mutations analyzed are not
null alleles and form THO complexes that are competent for
chromatin recruitment.
Sub2 is poorly recruited to active chromatin in both hpr1-
101 and hpr1-103 mutants. The facts that the presence of THO
at the site of transcription elongation helps recruit Sub2 to
transcribed chromatin (1, 46) and that multicopy SUB2 is able
to suppress hpr1 (11, 19) are consistent with the hypothesis
that Sub2 recruitment to the nascent mRNA plays a key role in
gene expression. As THO is as stable in both hpr1-101 and
hpr1-103 mutants as in wild-type cells, we wondered whether
their respective phenotypes could be caused by different levels
of Sub2 recruitment to transcribed chromatin. While testing
this possibility, we first noticed that with a lacZ-URA3 trans-
lational fusion under the control of the tet promoter (LAUR
system) (19), SUB2 overexpression suppressed the transcrip-
tional defects of both the hpr1-101 and hpr1-103 mutants (Fig.
9A). This was consistent with the possibility that Sub2 was not
efficiently recruited to transcribed chromatin in both mutants.
Again, hpr1-103 showed a transcription defect in extra-long
DNA sequences (Fig. 9A) that reinforces the conclusion that
hpr1-103 is a leaky rather than a separation-of-function muta-
tion.
Sub2 recruitment to active chromatin was directly assayed
by ChIP in strains carrying a SUB2-TAP epitope fusion at the
SUB2 chromosomal locus with Sepharose IgG and anti-
RNAPII antibodies. As shown in Fig. 9B, there was no signif-
icant difference in the recruitment of RNAPII to the constitu-
tively transcribed PMA1 gene between the wild-type and hpr1
mutant strains tested. Nevertheless, recruitment of Sub2-TAP
was as inefficient in hpr1-101 and hpr1-103 cells as in hpr1
cells (55 to 60% of the wild-type level). Therefore, we can
conclude that the specific gene expression phenotype of hpr1-
FIG. 6. Nascent-mRNA dependency of the transcription and hy-
perrecombination defects of hpr1 mutants. (A) Kinetic analyses of
transcription activation of the ribm and Rib fusions in strains
W303-1A (WT [wild type]), WH101-1A (hpr1-101), WH103-1A (hpr1-
103), and U678-4C (hpr1). The PHO5-ribm-lacZ (ribm) and PHO5-
Rib-lacZ (Rib) transcriptional fusions were under control of the
GAL1 promoter (GAL1p). They contain an active or inactive (respec-
tively), synthetically made, 52-bp ribozyme (Rib), followed by a 266-bp
fragment of the U3 gene to prevent the cleaved mRNA from degra-
dation and the 369-bp PvuII 3-end lacZ fragment at the untranslated
region of PHO5 (position 1405). Samples were collected 2 h after
galactose addition to activate transcription. Electrophoresis was per-
formed with formaldehyde-agarose gels (ribm) or urea-acrylamide gels
(Rib), and hybridization was with a U3 probe, corresponding to the
ribm and Rib region in the scheme. All data were normalized with
respect to the endogenous U3 signal. The average of three different
experiments is plotted. A.U., arbitrary units. (B) Recombination fre-
quencies of wild-type, hpr1, hpr1-101, and hpr1-103 cells containing the
recombination systems GL-Rib (black bars) and GL-ribm (gray bars)
are shown. Each recombination frequency is the median value of six
independent colonies. The average median value of two to four exper-
iments and the standard deviation are plotted.
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101 mutants is not caused by different abilities to recruit Sub2
to the nascent mRNA and that inefficient Sub2 recruitment is
not enough to trigger either the recombination or the tran-
scription phenotype of THO mutants.
Replication fork progression is slowed down in hpr1-103 but
not in hpr1-101. We have recently shown that in hpr1 mu-
tants, hyperrecombination correlates with cell cycle-specific
transcription (43). While S-phase-specific transcription was ca-
pable of inducing recombination, G2-specific transcription was
not. At the molecular level, replication of the transcribed lacZ
gene was accompanied with a slowdown of the replication fork
during S phase. This slowdown was dependent on both tran-
scription and RNA. We therefore reasoned that the absence of
hyperrecombination in hpr1-101 mutants could be explained if
reduced transcription was not associated with slowed-down
replication fork progression. To test this possibility, we ana-
lyzed replication intermediates of plasmid pRWY005, which
contains a replication origin facing the lacZ ORF driven by the
GAL1 promoter (Fig. 10A). As shown in Fig. 10B, in contrast
to the wild-type intermediates, hpr1 replication intermediates
appear to accumulate around the inflection point (white ar-
row) and the bubble arc signal gets weaker, indicating a slow-
down of fork progression within lacZ. However, such an accu-
mulation of simple-Y molecules was not obvious in hpr1-101
cells, and the intensities of the bubble arc signals were similar
in the hpr1-101 and wild-type strains. In contrast, replication
intermediates from hpr1-103 cells accumulated at the inflection
point and toward the 2n spike, although to a lesser extent than
in hpr1 (Fig. 2). These results are consistent with the idea that
transcription-associated hyperrecombination of THO mutants
is linked to replication fork progression defects (43) and sug-
gest that transcription impairment in hpr1-101 mutants does
not lead to structures capable of slowing down or disrupting
replication fork progression. Instead, the mild transcription
defect of hpr1-103 seems to be sufficient to impair replication
FIG. 7. Analysis of the THO complex in different hpr1 mutants.
(A) Western analysis (top) and Coomassie staining (bottom) of total
protein extracts from isogenic strains WWT2T (WT [wild type]),
WTT3-4A (hpr1-101), WTT4-5C (hpr1-103), MTT1 (mft1), STT2
(sub2), and WTT3-4C (hpr1) harboring a Tho2-TAP fusion sub-
jected to SDS-PAGE and hybridized with PAP antibody recognizing
the TAP epitope. Either the same amount or a 10-fold excess (marked
with an asterisk) of the total proteins shown in the Coomassie-stained
gel was loaded for each mutant. (B) Silver-stained gradient SDS-
PAGE of purified THO complex from the wild type and hpr1 mutants.
The amount of the eluted fraction loaded in each case was calculated
to get the same amounts of TAP-purified Tho2 protein. Arrows indi-
cate the bands corresponding to the four THO subunits (black, de-
tectable; white, nondetectable). The two additional bands observed in
hpr1 strains may correspond to Tho2 degradation products, as sug-
gested by Western analyses (data not shown), but this needs further
confirmation. (C) Western analysis of the purified eluted Tho2-TAP
fraction subjected to 8% SDS-PAGE and hybridized with anti-Mft1
antibody. Others details are the same as those in panel A. Amounts of
protein extracts (marked with an asterisk) similar to those used for
panel B or 10-fold excesses were loaded for each mutant.
FIG. 8. Recruitment of Tho2 to active chromatin in hpr1-101 and
hpr1-103 cells, as determined by ChIP analysis of Tho2-TAP to the
PMA1 gene. Experiments were performed with strains WWT2T
(W303-1A THO2-TAP), WTT3-4A (W303-1A THO2-TAP hpr1-101),
WTT3-4C (W303-1A THO2-TAP hpr1::KAN), and WTT4-5C (W303-
1A THO2-TAP hpr1-103). For each genotype, ChIPs were performed for
two different cultures each and quantitative PCRs were repeated twice for
each culture. The scheme of the gene analyzed and the DNA fragments
amplified by PCR are shown. Other details are the same as those in Fig.
4. WT, wild type.
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FIG. 9. Recruitment of Sub2 to active chromatin in hpr1-101 cells. (A) Suppression of the lacZ gene expression defect of hpr1-101 and hpr1-103
by multicopy SUB2 as determined by Northern analysis. Strains W303-1A (WT [wild type]), WH101-1A (hpr1-101), and WH103-1A (hpr1-103)
were transformed with pCM184-LAUR containing the lacZ-URA3 fusion under the control of the tet promoter (scheme on top) and with either
multicopy plasmid YEp351-SUB2 carrying SUB2 () or empty vector YEp351 (). The experiment was performed in the presence of doxycycline
to induce transcription. Others details are the same as those in Fig. 3. (B) ChIP analysis of Sub2-TAP and RNAPII at the PMA1 gene. The scheme
of the genes analyzed and the PCR fragments amplified by PCR are shown at the top, Northern analyses of PMA1 expression in WT and hpr1
strains are shown in the middle, and ChIP results are at the bottom. Experiments were performed with strain BSU-S2T-6D (hpr1) carrying the
chromosomal Sub2-TAP construct and transformed with plasmid YCpA13 (HPR1), YCp-hpr1-101 (hpr1-101), or YCp-hpr1-103 (hpr1-103) or the
empty vector YCp70 (hpr1). For each genotype, ChIPs were performed with two different transformants each, and PCRs were repeated three
times in each case. One representative PAGE gel for each experiment is shown, with the PCR fragment corresponding to the 9716-to-9863
intergenic region of chromosome V used as a control (indicated by an asterisk). The rest of the PCR bands correspond to the specific gene
fragments analyzed (see Materials and Methods). The relative abundance of each DNA fragment was calculated as the ratio of each DNA
fragment to the intergenic-region quantification results of the precipitated fractions (P) normalized to the corresponding ratios of the input
fractions (I).
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fork progression, consistent with its hyperrecombination phe-
notype.
DISCUSSION
Here we report the isolation and molecular characterization
of novel THO complex mutations hpr1-103, which produces
mutants similar to hpr1-null mutants but with weaker pheno-
types, and hpr1-101, which impairs transcription and RNA
export without causing hyperrecombination. As in hpr1, the
transcriptional defect of hpr1-101 is dependent on the nascent
RNA from highly transcribed long and GC-rich DNA se-
quences, but it is not sufficient to impair replication fork pro-
gression. Therefore, this study indicates that hyperrecombina-
tion in all of the THO mutants so far studied is always linked
to a transcription defect but that impaired RNAPII processiv-
ity alone is not sufficient to induce hyperrecombination as long
as replication is not affected. These findings suggest that it is
possible to separate the mechanism(s) responsible for mRNA
biogenesis defects from the further step of triggering transcrip-
tion-dependent recombination by THO/TREX dysfunction.
Hyperrecombination requires a threshold level of transcrip-
tion impairment. Impaired transcription and hyperrecombina-
tion are hallmark phenotypes of mutants of the THO complex
(Fig. 2). Out of the screen for mutants that allow the dissection
of these two phenotypes, hpr1-103, together with hpr1-102 and
hpr-104, contains multiple point mutations and shows interme-
diate effects on gene expression and genetic instability, which
can be explained by leakiness. Indeed, one of these mutations,
hpr1-102, is a carboxy-terminal truncation similar to the first,
leaky, hpr1-1 mutation identified (4). Of the three leaky mu-
tants, hpr1-103 is particularly interesting because of its clear
hyperrecombination phenotype and weak effect on transcrip-
tion. A close look at its phenotypes validates our model in
which hpr1-mediated hyperrecombination is a consequence of
defective transcription. Thus, transcription impairment in
hpr1-103 is detected in DNA sequences such as the lacZ-URA3
fusion, and RNAPII processivity impairment is detected in
long ORFs such as YLR454. In the direct-repeat construct
(L-lacZ) in which hyperrecombination was observed in hpr1-
103, transcription is also clearly reduced, validating the general
conclusion that hyperrecombination in THO mutants is linked
to a transcription defect. Indeed, hyperrecombination is only
observed in hpr1-103 when the recombination system is tran-
scribed and depends on the nascent mRNA molecule. Consis-
tently, in hpr1-103 mutants, recruitment of the Sub2 subunit of
TREX to transcribed chromatin is impaired and poly(A)
RNA is accumulated in the nuclei, although to a lesser extent,
as in hpr1-null mutants, indicating that hpr1-103 is also im-
paired in mRNP formation. The phenotypes of hpr1-103 are
also in agreement with the idea that various kinds of aberrant
intermediates could be formed in the presence of a mutated
THO complex with different outcomes in transcription and
genomic instability. Therefore, the levels of hyperrecombina-
tion may not necessarily be proportional to the strength of the
transcriptional defect but may reflect the formation of thresh-
old levels of aberrant transcriptional intermediates, such as
the RNAPII-DNA-RNA ternary complex, stalled or paused
RNAPII, etc.
A nonhyperrecombinant allele, hpr1-101, confers the same
transcription and RNA export defects as hpr1. In contrast to
the hpr1-102 to -104 leaky alleles, mRNA accumulation of
DNA sequences such as lacZ in hpr1-101 cells are strongly
reduced, but this is not linked to hyperrecombination. Al-
though a weak increase in recombination is observed in this
mutant, the strong gene expression defect, which is similar to
that of hpr1 in lacZ, strongly suggests that its major type of
transcription defect is not linked to hyperrecombination. The
hpr1-101 mutation probably affects the quality of the mRNP
formed as well, and thus its transcription impairment is linked
to a synthetic lethality defect in combination with mex67-5 and
a weak mRNA export defect and is dependent on the nascent
mRNA molecule. However, our results clearly show that hpr1-
101 cells have a major impairment in transcription elongation,
as determined by ChIP, which reflects a defect in RNAPII
processivity, as previously shown for hpr1 (23, 36). Indeed,
hpr1-101 is synthetic lethal with the spt4 mutant of transcrip-
tion elongation (data not shown), as also observed for hpr1
(35). Furthermore, if the low levels of RNA were primarily due
to an increased RNA decay in hpr1-101, one could predict
suppression in cells lacking the Rrp6 3-5 exo-RNase subunit
of the nuclear exosome. However, lacZ mRNA levels re-
mained low in hpr1-101 rrp6 double mutants (data not
shown).
The gene expression defects of hpr1-101 are similar in in-
FIG. 10. Replication fork progression in hpr1-101 and hpr1-103
cells. (A) Scheme of the 6.26-kb pRWY005 yeast plasmid used for this
study (left) and 2D gel pattern of predictable replication intermediates
upon plasmid linearization (right). Depicted are restriction sites, func-
tional elements (ARS1, open circle; URA3, open arrow; GAL1 pro-
moter, open rectangle; lacZ gene, dashed arrow), and shapes of rep-
lication intermediates (a bubble and a Y). (B) 2D gel analysis of
replication intermediates within a 3.0-kb SacI-SmaI fragment isolated
from cells grown in galactose. The replication intermediates were
derived from strains W303-1A (WT [wild type]), SChY58a (hpr1),
WH101-1A (hpr1-101), and WH103-1A (hpr1-103) transformed with
plasmid pRWY005. The inflection point, containing simple-Y mole-
cules of which each arm has approximately the same length (white
arrow), is indicated.
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tensity to those observed for hpr1, including a selective im-
pairment of transcription and a nuclear accumulation of
poly(A) RNA that are consistent with suboptimal formation
of export-competent mRNPs. In favor of this conclusion is the
fact that, similar to hpr1 and hpr1-103 cells, hpr1-101 cells are
impaired in the ability to recruit Sub2 to transcribed chroma-
tin. Sub2, like its human ortholog UAP56 (37), may be an
RNA-dependent ATPase required for the cotranscriptional
formation of an export-competent mRNP particle. It functions
as a heterodimer together with the Yra1 RNA export factor as
part of the TREX complex (39, 40) and is recruited to the
transcribed chromatin in a THO-dependent manner (46). Our
observation that in hpr1-101 cells, overexpression of Sub2 sup-
presses the mRNA accumulation defect as in hpr1-103 and
hpr1 cells is consistent with the idea that the formation of
export-competent mRNPs in hpr1-101 mutants is caused by
their inability to recruit Sub2 properly to the nascent mRNA.
This means that in hpr1-101 mutants, a dysfunctional THO
complex incapable of promoting proper mRNP biogenesis and
export may be formed. However, the fact that Sub2 recruit-
ment is equally impaired in hpr1-101 and hpr1-103, as well as in
hpr1, mutants, despite the fact that the intensities of their
transcriptional and mRNA export defects are different,
strongly suggests that THO has an additional role in mRNP
biogenesis, regardless of its capability to help recruit Sub2 into
transcribed DNA.
THO constitutes a structural core independent of Sub2 that
is unstable in single THO-null mutants but not in hpr1-101 or
hpr1-103 mutants. An outcome of our work is that THO is a
biochemical and functional unit different from Sub2, suggest-
ing that THO may constitute a functional core complex apart
from the Sub2-Yra1 heterodimer. Null mutations in presum-
ably all THO genes, as shown for HPR1 and MFT1, but not in
the Sub2 component of TREX, led to the dissociation of the
whole THO complex and the degradation of presumably all
THO subunits, as shown for Tho2 (Fig. 7) (19). This could
explain the previously reported similarity of phenotypes among
the different THO-null mutants (9, 40). As the THO complex
present in hpr1-101 and hpr1-103 is loaded onto active chro-
matin at similar level as in the wild type, the different gene
expression defects of these mutants might be based on distinct
interactions between THO and the nascent mRNP or the tran-
scriptional apparatus or on the possibility that THO has sev-
eral biochemical activities, which would be differentially
affected by each point mutation.
The hpr1-101 allele leads to an L586P amino acid substitu-
tion in a well-conserved domain among Hpr1 orthologues from
different species from yeast to humans (Fig. 1B). Despite the
fact that the biological function of this protein domain in the
context of the whole protein is unknown, it seems that this
mutation could define a functional motif relevant to the mRNP
biogenesis function of THO. Although the change from L to P
could introduce a hinge in the protein structure and therefore
completely destroy the ability of the protein to interact with
other components of THO, our protein purification analysis
revealed that this is not the case and that the L residue is
essential for its role in mRNP biogenesis and its capacity to
facilitate Sub2 recruitment to actively transcribed DNA. The
similarity of the phenotypes of sub2 cells and THO-null mu-
tants (9, 19, 40) suggests that the integrity of a functional THO
complex is not sufficient to guarantee proper mRNP biogenesis
and export. Our study reveals the need for a functional TREX
complex (THO-Sub2, Yra1) at the transcription site for the
formation of an export-competent mRNP particle and con-
firms that THO constitutes a core structural unit apart from
Sub2-Yra1. This may be consistent with the facts that, as in S.
cerevisiae (9), THO has been purified independently of Sub2 in
Drosophila (32); that humans hHpr1 and hTho2 can be purified
apart from UAP56-Aly, orthologues of Sub2-Yra1 (24); and
that Sub2 recruitment to active chromatin, contrary to THO
recruitment, depends on RNA in yeast (1).
Hyperrecombination of hpr1 mutants correlates with im-
paired replication fork progression. The difference in THO
integrity between hpr1 and hpr1-101 confirms that, despite
the strong effect on transcription and mRNA export of hpr1-
101, the latter is not a null mutation. This conclusion is also
clear from the observation that hpr1-101, in contrast to all
THO-null single mutants, does not lead to hyperrecombina-
tion. This nonhyperrecombinant phenotype suggests that in
THO/TREX mutants, RNA-dependent transcriptional inter-
mediates resulting from impaired transcription elongation and
defective cotranscriptional mRNP formation may not neces-
sarily be sufficient to trigger hyperrecombination. This seems
to be the case for hpr1-101. Such a nonhyperrecombinogenic
intermediate may involve the nascent mRNA, as self-cleavage
of the nascent mRNA affected transcript accumulation and
recombination rates in all mutants, regardless of whether or
not they were hyperrecombinant (Fig. 6) (18). It may be that
the nascent RNA is different or that if it is the same, it is
insufficient by itself to trigger hyperrecombination. Instead, a
further recombinogenic step would be required. Several re-
ports suggest that R loops can be intermediates associated with
hyperrecombination in different systems (18, 21, 45). It may be
that R loops represent a previous or cooperative step in hy-
perrecombination and, in addition, an mRNA-RNAPII-DNA
tertiary structure able to obstruct replication or the action of a
modifying enzyme (such as hAID in class switching), etc.,
would be required to trigger recombination.
We have recently shown that transcription impairment of
hpr1 along a highly transcribed lacZ gene causes a retarda-
tion of replication, observed as a slowdown of fork progression
(43). This slowdown of fork progression could partially be
suppressed by ribozyme-mediated cleavage of the mRNA. As
mitotic recombination is a postreplicative DNA repair pathway
of, primarily, replication-dependent DNA breaks (25, 26, 34),
it seems that in THO-null mutants only RNA-dependent tran-
scriptional intermediates that interfere with replication are
able to induce recombination. Consistent with this idea, tran-
scription-dependent hyperrecombination in hpr1 is S phase
dependent (43). Indeed, replication is impaired in the hyper-
recombinant hpr1-103 mutant but not in hpr1-101, consistent
with the idea that hyperrecombination in THO mutants cor-
relates with replication fork impairment.
Different possibilities could explain why, in the absence of a
fully functional THO complex, replication fork progression is
affected whereas this is not the case in hpr1-101 cells. One
possibility is that elongating RNAPII or another RNA-protein
intermediate could be released from the transcription site in
wild-type and hpr1-101 cells via, directly or indirectly, a THO-
dependent function still present in Hpr1-101 complexes. Con-
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sistently, THO remains stable and seems to be recruited into
chromatin in both hpr1-101 and hpr1-103 mutants. Further
research is required to understand this, and the hpr1-101 mu-
tation may be a useful tool with which to dissect both the
mechanism(s) leading to impaired mRNP biogenesis and the
transcription-dependent structure responsible for replication
impairment and genomic instability in both THO/TREX mu-
tants and wild-type cells.
In summary, this study indicates that transcription elonga-
tion in THO mutants can be impaired without leading to a
downstream intermediate at the site of transcription responsi-
ble for hyperrecombination, unless such an intermediate im-
pairs replication fork progression. The RNAPII processivity
defect in THO mutants may reflect the inability of RNAPII to
progress further if mRNP is not properly formed. Whether or
not there is a checkpoint mechanism mediated by THO that
causes RNAPII to halt or reduce elongation is an attractive
possibility to be tested. In this scenario, a further mRNA-
dependent step (formation of aberrant mRNA-RNAPII-DNA
tertiary structures, etc.) able to impair replication fork pro-
gression would be required to cause hyperrecombination.
This could be a general feature conserved from bacteria to
eukaryotes, as transcription may be an obstacle to replica-
tion (28, 41).
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